Author:
Haisma Bauke,Schols Saskia E.M.,van Oerle René G.M.,Verbeek-Knobbe Kitty,Hellenbrand Dave,Verwoerd Evelien J.,Heubel-Moenen Floor C.J.I.,Stroobants An K.,Meijer Danielle,Rijpma Sanna R.,Henskens Yvonne M.C.
Reference47 articles.
1. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias;Acharya;J. Thromb. Haemost.,2004
2. Haemophilia;Berntorp;Nat. Rev. Dis. Primers,2021
3. Health care costs and resource use of managing hemophilia A: a targeted literature review;Chen;J. Manag. Care Spec. Pharm.,2023
4. Health care resource utilization and cost burden of hemophilia B in the United States;Buckner;Blood Adv.,2021
5. Treatment of patients with rare bleeding disorders in the Netherlands: real-life data from the RBiN study;Maas;J. Thromb. Haemost.,2022